Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 35-yr-old man with thyrotoxicosis, ultimately attributed to Graves' disease in whom antithyroid drug used initially was soon discontinued, due to abnormal liver function, and replaced by Lugol's solution. Three weeks l...

We review the results of our work on the iodine interaction with thioamides, selenoamides, and amides. Complexes with (i) "spoke" or "extended spoke" structures, D . I(2) and D . I(2) . I(2), respectively, (D is the ligand donor) (ii) iodonium salts of {[D(2) - I](+)[I(n)](-)} (n = 3, 7) and {[D(2) - I](+)[FeCl(4)](-)} formulae and (iii) disulfides of the categories (a) [D - D], (b) {[D - DH](+...

Thyrotoxicosis is a common disorder, especially in women. The most frequent cause is Graves' disease (autoimmune hyperthyroidism). Other important causes include toxic nodular hyperthyroidism, due to the presence of one or more autonomously functioning thyroid nodules, and thyroiditis caused by inflammation, which results in release of stored hormones. Antithyroid drugs are the usual initial tr...

Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism, with recurrent muscle paralysis and hypokalemia that are caused by an intracellular shift of potassium. TPP is relatively common in Asian males, but is extremely rare in children and adolescents, even for those of Asian descent. We describe a 16-year-old Korean adolescent presenting with a two-week history of episodi...

Ophthalmopathy is one of the known presenting features of Grave’s disease. Its due to development of antithyroid receptor antibodies. Rarely it may be associated with thyroid malignancies developing in the Grave’s nodule. There are few case reports of patients with coexisting thyroid associated orbitopathy (TAO) and thyroid carcinoma. Sometimes it may be the presenting symptom of an occult thyr...

A 32-year-old female case of large thymic hyperplasia with hyperthyroidism is reported. A computed tomography (CT) examination disclosed a large mediastinal mass (16 x 11 cm) with a heterogeneous internal structure containing both soft tissue density areas and fat density areas. The mass was histologically diagnosed as thymic lymphoid hyperplasia. The thymic mass enlarged during hyperthyroidism...

Antithyroid drugs have been used for more than 50 years for the management of hyperthyroidism. Most patients tolerate treatment well but some may develop life-threatening side effects such as agranulocytosis, aplastic anemia and cholestatic hepatitis. A 45-year-old female was diagnosed with severe hyperthyroidism. Treatment with Carbimazole 30 mg/day was initiated. Within six weeks following th...

Neutropenia is a common side-effect in hyperthyroid patients with long-term use of antithyroid drugs. This may be caused by drug-induced immune dysfunction or increased thyroxine hematologic toxicity, which usually returns to normal after medication is discontinued or the hyperthyroidism becomes well controlled. However, hyperthyroidism with pancytopenia is extremely rare. The current case repo...

We review the results of our work on the iodine interaction with thioamides, selenoamides, and amides. Complexes with (i) “spoke” or “extended spoke” structures, D · I2 and D · I2 · I2, respectively, (D is the ligand donor) (ii) iodonium salts of {[D2 − I][In]} (n = 3, 7) and {[D2 − I][FeCl4]} formulae and (iii) disulfides of the categories (a) [D − D], (b) {[D−DH][I3]} have been isolated and c...

2014 Aim: The aim of this study was to determine the relationship between thyroid disorders and prolactin in patients with and without lupus activity. Patients & methods: Women with systemic lupus erythematosus (SLE) were evaluated for lupus activity. Serum tri-iodothyronine (T3), serum thyroxine (T4) and thyroid-stimulating hormone (TSH), anti-thyroid peroxidase (anti-TPO) anti-thyroglobulin (...